Status:

COMPLETED

Prevalence of FID and QoL in Patients with Oncological and with Haematological Malignancies

Lead Sponsor:

Luzerner Kantonsspital

Conditions:

Functional Iron Deficiency

Eligibility:

All Genders

18+ years

Brief Summary

Prospective single-center observational study assessing prevalence of FID (Laboratory work-up) and Quality of Life (Questionnaire) in adult patients with oncological and with haematological malignanci...

Detailed Description

Patients included into the study will have a laboratory work-up assessing the occurence of functional iron deficiency using laboratory parameters (full blood count, reticulocytes, transferrin saturati...

Eligibility Criteria

Inclusion

  • Age \> 18 years
  • Patients with oncological (solid tumors) and with haematological malignancies (non-solid tumors, including Plasma cell myeloma, lymphoma, myeloproliferative neoplasias \[MPN\], myelodysplastic syndromes \[MDS\] and chronic leukemias)
  • Within four weeks prior to disease-directed systemic therapy
  • Participation in other trials is possible

Exclusion

  • Known iron deficiency with or without iron substitution p.o. or i.v. within last 8 weeks prior to inclusion into this trial
  • Therapy with RBC-transfusions within last 8 weeks prior to inclusion into this trial
  • Therapy with ESA within last 8 weeks prior to inclusion into this trial
  • Malignancies with acute need for therapeutic intervention (e.g. acute leukemias, superior vena cava obstruction, etc.)
  • Pregnancy
  • Any other serious underlying medical, psychiatric, psychological, familial or geographical condition, which in the judgment of the investigator may interfere with the trial
  • Inability to give consent

Key Trial Info

Start Date :

February 7 2022

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

April 4 2023

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT05333913

Start Date

February 7 2022

End Date

April 4 2023

Last Update

March 28 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Luzerner Kantonsspital

Lucerne, Canton of Lucerne, Switzerland, 6000

Prevalence of FID and QoL in Patients with Oncological and with Haematological Malignancies | DecenTrialz